malignant tissue samples; adjacent normal tissue samples
-
not specified
Microarray; RT-qPCR; RNase R Treatment; Sanger Sequencing; Clinical Sample Validation; ROC Analysis; Cohort Study
Discriminates malignant vs adjacent normal prostate tissue (AUC 0.743).
circCRIM1 is down-regulated in prostate cancer tissue and was evaluated primarily as a diagnostic tissue biomarker distinguishing tumor from adjacent normal tissue, without mechanistic functional experiments in this study.
0.6663
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors.
combined biological and clinical study